Evidence map›Paper›PMID 27562666›Full record

ArticlePsychopharmacology2016

Prevention of unpredictable chronic stress-related phenomena in zebrafish exposed to bromazepam, fluoxetine and nortriptyline.

Matheus Marcon, Ana P Herrmann, Ricieri Mocelin, Cassiano L Rambo, Gessi Koakoski, Murilo S Abreu, Greicy M M Conterato, Luiza W Kist, Maurício R Bogo, Leila Zanatta and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Psychopharmacology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Animal Inflammation-Based Models of Neuropsychiatric Disorders.Advances in experimental medicine and biology · 2023
    Article
  10. Article
  11. Article
  12. Towards Modeling Anhedonia and Its Treatment in Zebrafish.The international journal of neuropsychopharmacology · 2022
    Article
  13. Review
  14. An Overview of Zebrafish Modeling Methods in Drug Discovery and Development.Advances in experimental medicine and biology · 2022
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Matheus MarconPrograma de Pós-Graduação em Ciências Ambientais, Universidade Comunitária da Região de Chapecó, Av. Senador Attílio Fontana, 591E, Chapecó, Santa Catarina, 89809-000, Brazil.
Ana P HerrmannGrupo de Estudos Biológicos e Clínicos em Patologias Humanas, Universidade Federal da Fronteira Sul, Campus Chapecó, SC 484 km 02, Chapecó, Santa Catarina, 89815-899, Brazil.
Ricieri MocelinPrograma de Pós-Graduação em Ciências Ambientais, Universidade Comunitária da Região de Chapecó, Av. Senador Attílio Fontana, 591E, Chapecó, Santa Catarina, 89809-000, Brazil.
Cassiano L RamboPrograma de Pós-Graduação em Biologia Celular e Molecular, Pontifícia Universidade Católica do Rio Grande do Sul, Av. Ipiranga, 6681, Porto Alegre, RS, 90619-900, Brazil.
Gessi KoakoskiPrograma de Pós-Graduação em Farmacologia, Universidade Federal de Santa Maria, Campus Universitário, Camobi, Santa Maria, Rio Grande do Sul, 97105-900, Brazil.
Murilo S AbreuPrograma de Pós-Graduação em Farmacologia, Universidade Federal de Santa Maria, Campus Universitário, Camobi, Santa Maria, Rio Grande do Sul, 97105-900, Brazil.
Greicy M M ConteratoLaboratório de Fisiologia da Reprodução Animal, Universidade Federal de Santa Catarina, Rodovia Ulisses Gaboardi, km 3, Centro de Curitibanos, Curitibanos, Santa Catarina, 89520-000, Brazil.
Luiza W KistPrograma de Pós-Graduação em Biologia Celular e Molecular, Pontifícia Universidade Católica do Rio Grande do Sul, Av. Ipiranga, 6681, Porto Alegre, RS, 90619-900, Brazil.
Maurício R BogoPrograma de Pós-Graduação em Biologia Celular e Molecular, Pontifícia Universidade Católica do Rio Grande do Sul, Av. Ipiranga, 6681, Porto Alegre, RS, 90619-900, Brazil.
Leila ZanattaPrograma de Pós-Graduação em Ciências Ambientais, Universidade Comunitária da Região de Chapecó, Av. Senador Attílio Fontana, 591E, Chapecó, Santa Catarina, 89809-000, Brazil.
Leonardo J G BarcellosPrograma de Pós-Graduação em Farmacologia, Universidade Federal de Santa Maria, Campus Universitário, Camobi, Santa Maria, Rio Grande do Sul, 97105-900, Brazil.
Angelo L PiatoLaboratório de Psicofarmacologia e Comportamento, Programa de Pós-Graduação em Farmacologia e Terapêutica, ICBS, Universidade Federal do Rio Grande do Sul, Av. Sarmento Leite 500/305, Porto Alegre, Rio Grande do Sul, 90050-170, Brazil. angelopiato@ufrgs.br.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

rationaleSeveral model organisms have been employed to study the impacts of stress on biological systems. Different models of unpredictable chronic stress (UCS) have been established in rodents; however, these protocols are expensive, long-lasting, and require a large physical structure. Our group has recently reported an UCS protocol in zebrafish with several advantages compared to rodent models. We observed that UCS induced behavioral, biochemical, and molecular changes similar to those observed in depressed patients, supporting the translational relevance of the protocol.

objectivesConsidering that a pharmacological assessment is lacking in this zebrafish model, our aim was to evaluate the effects of anxiolytic (bromazepam) and antidepressant drugs (fluoxetine and nortriptyline) on behavioral (novel tank test), biochemical (whole-body cortisol), and molecular parameters (cox-2, tnf-α, il-6, and il-10 gene expression) in zebrafish subjected to UCS.

resultsWe replicated previous data showing that UCS induces behavioral and neuroendocrine alterations in zebrafish, and we show for the first time that anxiolytic and antidepressant drugs are able to prevent such effects. Furthermore, we extended the molecular characterization of the model, revealing that UCS increases expression of the pro-inflammatory markers cox-2 and il-6, which was also prevented by the drugs tested.

conclusionsThis study reinforces the use of zebrafish as a model organism to study the behavioral and physiological effects of stress. The UCS protocol may also serve as a screening tool for evaluating new drugs that can be used to treat psychiatric disorders with stress-related etiologies.

Indexed as

AnimalsAnti-Anxiety AgentsAntidepressive AgentsBehavior, AnimalBromazepamCyclooxygenase 2Disease Models, AnimalFemaleFluoxetineHydrocortisoneInterleukin-10Interleukin-6MaleNeurosecretory SystemsNortriptylineStress, PsychologicalAnti-Anxiety AgentsAntidepressive AgentsBromazepamCyclooxygenase 2FluoxetineHydrocortisoneInterleukin-10Interleukin-6NortriptylineTumor Necrosis Factor-alphaAntidepressantsAnxiolyticsCortisolCytokinesUnpredictable chronic stress

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.